Streetbeat News

Stock Prices

WDC

Western Digital (NASDAQ:WDC) received 9 analyst ratings in the last quarter, with an average price target of $49.33, representing an upside from the current price of $46.6. The average price target has increased by 18.16% from the previous target of $41.75. The ratings include 1 bullish, 4 somewhat bullish, and 4 indifferent, with no bearish or somewhat bearish ratings.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 9:00 pm

GDDY

GoDaddy (NYSE:GDDY) has received 6 analyst ratings in the last quarter, with 3 bullish, 1 somewhat bullish, and 2 indifferent. The average 12-month price target among these analysts is $96.17, with a high of $110.00 and a low of $80.00, representing a slight decrease from the previous target of $97.00. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 9:00 pm

APD

Over the past 20 years, Air Products & Chemicals (NYSE:APD) has produced an average annual return of 9.6%, outperforming the market. A $100 investment in APD 20 years ago would be worth $625.02 today. The company currently has a market cap of $61.55 billion.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 9:00 pm

SPGI

Over the past decade, S&P Global (NYSE:SPGI) has delivered an average annual return of 18.81%, outperforming the market. A $100 investment in SPGI 10 years ago would be worth $559.60 today. The company's market cap stands at $130.87 billion.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 9:00 pm

PPL

PPL Corporation (NYSE:PPL) has received 5 analyst ratings in the last quarter, with 3 being somewhat bullish and 2 indifferent. The average price target is $27.6, representing an implied upside from the current price of $26.18. This target has decreased by 4.83% from the previous target of $29.00. Analysts rate stocks to provide investment guidance, but their ratings are opinions and should be used with other research.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 9:00 pm

NSTG

NanoString Technologies' stock (NSTG) trades lower following a downgrade by Baird from Outperform to Neutral, with a price target reduction from $4 to $0.75.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 8:38 pm

F

GM

NFLX

PARA

PARAA

STLA

General Motors Company (GM) has decided not to spend on Super Bowl LVIII commercials, a move that may be related to cost-cutting measures following a UAW strike. The strike could lead to billions in losses for Detroit's big three automakers, including GM, and has resulted in increased wages for UAW employees. GM's CEO Mary Barra has announced delays in electric vehicle launches and cost-cutting initiatives. Stellantis (STLA) and Ford Motor Company (F) were also targeted by UAW strikes, with Ford's CEO expressing a preference for vehicle updates over Super Bowl ads.

Portfolio Pulse from Chris Katje

November 21, 2023 | 8:35 pm

CBDD

CBD of Denver, Inc. (OTCPK: CBDD) partners with Channel 21 in Germany to sell its Magic Lappen via teleshopping. The company reports Q3 sales of $677,893, a significant increase from the previous year, and a reduced net loss from operations. CBDD's stock was down 5.56% at $0.0008 per share.

Portfolio Pulse from Joana Scopel

November 21, 2023 | 8:32 pm

NVO

Novo Nordisk A/S (NYSE:NVO) is facing a significant surge in demand for its diabetes drug Ozempic (semaglutide) and will restrict its starter kit supplies in Europe. The company will also temporarily reduce the supply of another diabetes drug, Victoza (liraglutide), to focus on Ozempic production. Intermittent shortages of Ozempic are expected through 2024, with Victoza shortages lasting until Q2 2024. Novo Nordisk advises against starting new patients on Victoza until supplies normalize and to limit new patient initiations on Ozempic. The company announced a DKK 42 billion investment to expand manufacturing in Denmark, including for GLP-1 products like Ozempic. Novo Nordisk's stock is slightly down by 0.31% at $103.24.

Portfolio Pulse from Vandana Singh

November 21, 2023 | 8:30 pm

PRST

Presto Automation's stock is trading lower following the announcement of a year-over-year decline in Q1 revenue and the issuance of Q2 guidance that may have disappointed investors.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 8:30 pm